Mab Cure Inc is categorized under In-Vitro In-Vivo Diagnostic Substance Manufacturers in White Plains, NY .
Mab Cure Inc was established in 0, and today employs 1 to 4, earning Unknown per year. This is a In-Vitro In-Vivo Diagnostic Substance Manufacturers business, which does work in the B2B market, and is classified as a In-Vitro In-Vivo Diagnostic Substance Manufacturers, under code number 3254130 by the NAICS.
If you are seeking more information, feel free to contact Amnon Gonenne, Chief Executive Officer Full Name Report at the company’s headquarters by writing to 21 Sparrow Circle, White Plains, New York NY 10605 or by phoning (845) 591-3144 Full Phone Report. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
|Business Name:||Mab Cure Inc|
|Contact Person:||Amnon Gonenne, Chief Executive Officer Full Name Report|
|Address:||21 Sparrow Circle, White Plains, New York 10605|
|Phone Number:||(845) 591-3144 Full Phone Report|
|Annual Revenue (USD):||Unknown|
|Employee Number:||1 to 4|
|Business Type:||B2B (Business to Business)|
|Business Category:||In-Vitro In-Vivo Diagnostic Substance Manufacturers|
|Share This Business:|
Mab Cure Inc was started in 0 to provide professional In-Vitro In-Vivo Diagnostic Substance Manufacturers under the SIC code 2835 and NAICS code 3254130. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Amnon Gonenne, Chief Executive Officer Full Name Report for inquiries that concern Mab Cure Inc by calling the company number (845) 591-3144 Full Phone Report, as your correspondence is most welcome. Additionally, the physical location of the headquarters of Mab Cure Inc can be found at the coordinates 41.003002,-73.744557 as well as the street address 21 Sparrow Circle in White Plains, New York 10605.
For its online presence, you may visit Mab Cure Inc’s website at mabcure.com and engage with its social media outlets through on Twitter and on Facebook.